Search Results

By Syed Ali Abutalib, MD, and Sonali M. Smith, MD, FASCO  / September 25, 2019  / 2019 ASCO Annual Meeting

Update on Treatments Under Study for Chronic Lymphocytic Leukemia

The ASCO Post has offered comprehensive coverage of the 2019 ASCO Annual Meeting. To complement this news coverage, here are featured clinical trials of several treatments in chronic lymphocytic leukemia (CLL). They focus on the monoclonal antibody obinutuzumab in combination therapy in the CLL14...